SCM
CNMD icon

Segantii Capital Management’s CONMED CNMD Stock Holding History

Segantii Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-36,900
Closed -$3.72M – 152
2023
Q3 		$3.72M Buy
+36,900
New +$4.24M 0.13% 71
2022
Q3 		– Sell
-2,940
Closed -$282 – 558
2022
Q2 		$282 Buy
+2,940
New +$353K 0.01% 437

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Segantii Capital Management's CNMD Position: Q4 2023 in Review

Segantii Capital Management sold out of CONMED (CNMD) in Q4 2023, closing a stake of 36,900 shares — an estimated $3.72M sold.

Segantii Capital Management first reported a position in CNMD in Q2 2022 and held it in 2 quarters. The position peaked at $3.72M in Q3 2023. 306 funds tracked by Wall St. Rank hold CNMD as of Q4 2023.

  • Segantii Capital Management reported no remaining CONMED position as of Q4 2023 after selling out during the quarter.
  • Segantii Capital Management sold 36,900 CONMED shares in Q4 2023, an estimated $3.72M.
  • Segantii Capital Management first reported a position in CONMED in Q2 2022 and held it in 2 quarters.
  • Segantii Capital Management's CONMED position peaked at $3.72M in Q3 2023.
  • 306 funds tracked by Wall St. Rank held CONMED as of Q4 2023.

Based on Segantii Capital Management's 13F filing for Q4 2023, filed 7 Feb 2024.